Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (171-180 of 750) with videos related to

Pageof 75
Sort By:
Alimentary Pharmacology & Therapeutics|October 15, 2025
Social Determinants of Health in Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific MortalityDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2017
Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysisSiddharth Singh, Antonio Facciorusso, Rohit Loomba, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2025
Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD-Insights From a National Analysis. Authors' ReplyDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|July 18, 2020
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASHTheresa J Hydes, Sujan Ravi, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)|May 19, 2023
Reply: People living with HIV and NAFLD and updated guidance on NAFLD screeningMary E Rinella, Norah Terrault, Brent Neuschwander-Tetri, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2022
Review article: current and emerging therapies for the management of cirrhosis and its complicationsElliot B Tapper, Nneka N Ufere, Daniel Q Huang, et al.
Hepatology (Baltimore, Md.)|July 29, 2009
Advances in pediatric nonalcoholic fatty liver diseaseRohit Loomba, Claude B Sirlin, Jeffrey B Schwimmer, et al.
Gastroenterology|February 2, 2020
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert ReviewRohit Loomba, Joseph K Lim, Heather Patton, et al.
Hepatology (Baltimore, Md.)|March 6, 2024
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver diseaseFasiha Kanwal, Brent A Neuschwander-Tetri, Rohit Loomba, et al.
Cancer|April 16, 2020
Have incidence rates of liver cancer peaked in the United States?Jessica L Petrick, Andrea A Florio, Rohit Loomba, et al.
Pageof 75

Showing results (171-180 of 750) with videos related to

Sort By:
Pageof 75
Alimentary Pharmacology & Therapeutics|October 15, 2025
Social Determinants of Health in Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific MortalityDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2017
Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysisSiddharth Singh, Antonio Facciorusso, Rohit Loomba, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2025
Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD-Insights From a National Analysis. Authors' ReplyDonghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, et al.
Clinical and Molecular Hepatology|July 18, 2020
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASHTheresa J Hydes, Sujan Ravi, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)|May 19, 2023
Reply: People living with HIV and NAFLD and updated guidance on NAFLD screeningMary E Rinella, Norah Terrault, Brent Neuschwander-Tetri, et al.
Alimentary Pharmacology & Therapeutics|March 2, 2022
Review article: current and emerging therapies for the management of cirrhosis and its complicationsElliot B Tapper, Nneka N Ufere, Daniel Q Huang, et al.
Hepatology (Baltimore, Md.)|July 29, 2009
Advances in pediatric nonalcoholic fatty liver diseaseRohit Loomba, Claude B Sirlin, Jeffrey B Schwimmer, et al.
Gastroenterology|February 2, 2020
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert ReviewRohit Loomba, Joseph K Lim, Heather Patton, et al.
Hepatology (Baltimore, Md.)|March 6, 2024
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver diseaseFasiha Kanwal, Brent A Neuschwander-Tetri, Rohit Loomba, et al.
Cancer|April 16, 2020
Have incidence rates of liver cancer peaked in the United States?Jessica L Petrick, Andrea A Florio, Rohit Loomba, et al.
Pageof 75